메뉴 건너뛰기




Volumn 15, Issue 2, 2009, Pages 7-15

New high-throughput liquid chromatographic tandem mass spectrometry assay for therapeutic drug monitoring of carvedilol in children with congestive heart failure

Author keywords

Carvedilol; LC MS MS; Therapeutic drug monitoring

Indexed keywords


EID: 70350429350     PISSN: 18416624     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (12)

References (31)
  • 3
    • 0031907425 scopus 로고    scopus 로고
    • Guidelines for the interpretation of analytical toxicology results and unit of measurement conversion factors
    • Mar
    • Flanagan RJ. Guidelines for the interpretation of analytical toxicology results and unit of measurement conversion factors. Ann Clin Biochem. 1998 Mar;35 (Pt 2):261-267
    • (1998) Ann Clin Biochem. , vol.35 , Issue.PART 2 , pp. 261-267
    • Flanagan, R.J.1
  • 5
    • 27744481679 scopus 로고    scopus 로고
    • Treatment of heart failure in children
    • James N, Smith M. Treatment of heart failure in children. Current Paediatrics 2005;7:539-548
    • (2005) Current Paediatrics , vol.7 , pp. 539-548
    • James, N.1    Smith, M.2
  • 6
    • 40149088839 scopus 로고    scopus 로고
    • Contemporany management of pediatric heart failure
    • Feb
    • Margossian R. Contemporany management of pediatric heart failure. Expert Rev Cardiovasc Ther. 2008 Feb;6(2):187-197
    • (2008) Expert Rev Cardiovasc Ther , vol.6 , Issue.2 , pp. 187-197
    • Margossian, R.1
  • 7
    • 0035051393 scopus 로고    scopus 로고
    • Carvedilol as therapy in pediatric heart failure: An initial multicenter experience
    • Apr
    • Bruns LA, Chrisant MK, Lamour JM, et al. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience. J Pediatr 2001 Apr;138(4):457-458
    • (2001) J Pediatr , vol.138 , Issue.4 , pp. 457-458
    • Bruns, L.A.1    Chrisant, M.K.2    Lamour, J.M.3
  • 8
    • 0034956483 scopus 로고    scopus 로고
    • Efficacy and safety of carvedilol in infants with dilated cardiomyopathy: A preliminary report
    • Jan-Feb
    • Gachara N, Prabhakaran S, Srinivas S, et al. Efficacy and safety of carvedilol in infants with dilated cardiomyopathy: a preliminary report. Indian Heart J. 2001 Jan-Feb;53(1):74-78
    • (2001) Indian Heart J. , vol.53 , Issue.1 , pp. 74-78
    • Gachara, N.1    Prabhakaran, S.2    Srinivas, S.3    Al, E.4
  • 9
    • 0036342786 scopus 로고    scopus 로고
    • Intermediate effects of treatment with metoprolol or carvedilol in children with left ventricular systolic dysfunction
    • Aug
    • Williams RV, Tani LY, Shaddy RE. Intermediate effects of treatment with metoprolol or carvedilol in children with left ventricular systolic dysfunction. J Heart Lung Transplant. 2002 Aug;21(8):906-909
    • (2002) J Heart Lung Transplant. , vol.21 , Issue.8 , pp. 906-909
    • Williams, R.V.1    Tani, L.Y.2    Shaddy, R.E.3
  • 11
    • 34548570632 scopus 로고    scopus 로고
    • Carvedilol for children and adolescents with heart failure A randomized controlled trial
    • Sept
    • Shaddy RE, Boucek MM, Hsu DT, Boucek Rj, Canter CE, Mahony L, et al. Carvedilol for children and adolescents with heart failure a randomized controlled trial. JAMA 2007 Sept;298(10):1171-1179
    • (2007) JAMA , vol.298 , Issue.10 , pp. 1171-1179
    • Shaddy, R.E.1    Boucek, M.M.2    Hsu, D.T.3    Rj, B.4    Canter, C.E.5    Mahony, L.6
  • 12
    • 0036271469 scopus 로고    scopus 로고
    • Carvedilol therapy in pediatric patients with congestive heart failure: A study investigating clinical and pharmacokinetic parameters
    • May
    • Laer S, Mir TS, Behn F, et al. Carvedilol therapy in pediatric patients with congestive heart failure: a study investigating clinical and pharmacokinetic parameters. Am Heart J. 2002 May;143(5):916-922
    • (2002) Am Heart J. , vol.143 , Issue.5 , pp. 916-922
    • Laer, S.1    Mir, T.S.2    Behn, F.3
  • 13
    • 84869674096 scopus 로고    scopus 로고
    • European medicines agency: Updated priority list for studies into off-patent paediatric medicinal products
    • London April
    • European Medicines Agency: Updated priority list for studies into off-patent paediatric medicinal products; London, April 2007. Doc. Ref.EMEA/197972/2007. http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/ vol1/reg-2006-1901/reg-2006-1901-en.pdf
    • (2007) Doc.Ref.EMEA/197972/2007
  • 15
    • 0036067685 scopus 로고    scopus 로고
    • Enantioselective analysis of (R)and (S)carvedilol in human plasma by high-performance liquid chromatography
    • Lamprecht G, Gruber L, Stoschitzky K, Lindner W. Enantioselective Analysis of (R)and (S)Carvedilol in Human Plasma by High-Performance Liquid Chromatography, Chromatographia, 2006 ; 56,Suppl.,S-25-29
    • (2006) Chromatographia , vol.56 , Issue.SUPPL.
    • Lamprecht, G.1    Gruber, L.2    Stoschitzky, K.3    Lindner, W.4
  • 16
    • 2942564418 scopus 로고    scopus 로고
    • Determination of carvedilol in human plasma by high-performance liquid chromatography applying on-line deproteination and column switching
    • Lamprecht G, Stoschitzky K. Determination of Carvedilol in Human Plasma by High-Performance Liquid Chromatography Applying On-Line Deproteination and Column Switching, Chromatographia, 2004;59:551-554
    • (2004) Chromatographia , vol.59 , pp. 551-554
    • Lamprecht, G.1    Stoschitzky, K.2
  • 17
    • 34047276117 scopus 로고    scopus 로고
    • Quantification of carvedilol in human plasma by liquid chromatography using fluorescence detection: Application in pharmacokinetic studies
    • DOI 10.1016/j.jpba.2007.01.026, PII S0731708507000660
    • Zarghi A, Foroutan SM, Shafaati A, Khoddam A. Quantification of carvedilol in human plasma by liquid chromatography using fluorescence detection: application in pharmacokinetic studies. J Pharm Bio-med Anal. 2007 May; 44(1):250-253. (Pubitemid 46551580)
    • (2007) Journal of Pharmaceutical and Biomedical Analysis , vol.44 , Issue.1 , pp. 250-253
    • Zarghi, A.1    Foroutan, S.M.2    Shafaati, A.3    Khoddam, A.4
  • 19
    • 48449106180 scopus 로고    scopus 로고
    • Lanchote VL. Stereoselective analysis of carvedilol in human plasma and urine using HPLC after chiral derivatization
    • Jul
    • Peccinini RG, Ximenes VF, Cesarino EJ, Lanchote VL. Stereoselective analysis of carvedilol in human plasma and urine using HPLC after chiral derivatization. Biopharm Drug Dispos. 2008 Jul;29(5):280-288
    • (2008) Biopharm Drug Dispos , vol.29 , Issue.5 , pp. 280-288
    • Peccinini, R.G.1    Ximenes, V.F.2    Cesarino, E.J.3
  • 20
    • 0345276755 scopus 로고    scopus 로고
    • Measurement of carvedilol in plasma by high-performance liquid chromatography with electrochemical detection
    • Dec
    • Machida M, Watanabe M, Takechi S, Kakinoki S, Nomura A. Measurement of carvedilol in plasma by high-performance liquid chromatography with electrochemical detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Dec;798(2):187-191
    • (2003) J Chromatogr B Analyt Technol Biomed Life Sci , vol.798 , Issue.2 , pp. 187-191
    • MacHida, M.1    Watanabe, M.2    Takechi, S.3    Kakinoki, S.4    Nomura, A.5
  • 22
    • 33845761419 scopus 로고    scopus 로고
    • Does a stable isotopically labeled internal standard always correct analyte response? A matrix effect study on a LC/MS/MS method for the determination of carvedilol enantiomers in human plasma
    • Jan
    • Wang S, Cyronak M, Yang E. Does a stable isotopically labeled internal standard always correct analyte response? A matrix effect study on a LC/MS/MS method for the determination of carvedilol enantiomers in human plasma. J Pharm Biomed Anal.2007 Jan;43(2):701-707
    • (2007) J Pharm Biomed Anal , vol.43 , Issue.2 , pp. 701-707
    • Wang, S.1    Cyronak, M.2    Yang, E.3
  • 23
    • 16644378310 scopus 로고    scopus 로고
    • Enantioselective pharmacokinetics of carvedilol in human volunteers
    • Sept
    • Phuong NT, Lee BJ, Choi JK, Kang JS, Kwon KI. Enantioselective pharmacokinetics of carvedilol in human volunteers. Arch Pharm Res. 2004 Sept;27(9):973-977
    • (2004) Arch Pharm Res. , vol.27 , Issue.9 , pp. 973-977
    • Phuong, N.T.1    Lee, B.J.2    Choi, J.K.3    Kang, J.S.4    Ki, K.5
  • 24
    • 0035810755 scopus 로고    scopus 로고
    • Separation of carvedilol enantiomers in very small volumes of human plasma by capillary electrophoresis with laser-induced fluorescence
    • May
    • Behn F, Michels S, Läer S, Blaschke G. Separation of carvedilol enantiomers in very small volumes of human plasma by capillary electrophoresis with laser-induced fluorescence. J Chromatogr B Biomed Sci Appl. 2001 May;755(1-2): 111-117
    • (2001) J Chromatogr B Biomed Sci Appl , vol.755 , Issue.1-2 , pp. 111-117
    • Behn, F.1    Michels, S.2    Läer, S.3    Blaschke, G.4
  • 26
    • 7444230364 scopus 로고    scopus 로고
    • Stereoselective analysis of carvedilol in human plasma using HPLC/MS/MS after chiral derivatization
    • Nov
    • Yang E, Wang S, Kratz J, Cyronak MJ. Stereoselective analysis of carvedilol in human plasma using HPLC/MS/MS after chiral derivatization. J Pharm Biomed Anal. 2004 Nov;36(3):609-615
    • (2004) J Pharm Biomed Anal , vol.36 , Issue.3 , pp. 609-615
    • Yang, E.1    Wang, S.2    Kratz, J.3    Cyronak, M.J.4
  • 27
    • 34249718975 scopus 로고    scopus 로고
    • Single quadrupole mass spectrometry for pre-clinical pharmacokinetic analysis: Quantitation of carvedilol in dog plasma
    • Jun
    • McIntosh MP, Carlson BJ, Schorno KS, Rajewski RA. Single quadrupole mass spectrometry for pre-clinical pharmacokinetic analysis: quantitation of carvedilol in dog plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun;852(1-2):665-668
    • (2007) J Chromatogr B Analyt Technol Biomed Life Sci , vol.852 , Issue.1-2 , pp. 665-668
    • McIntosh, M.P.1    Carlson, B.J.2    Schorno, K.S.3    Rajewski, R.A.4
  • 28
    • 34249993546 scopus 로고    scopus 로고
    • Analysis of carvedilol in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry
    • Jun
    • Jeong DW, Kim YH, Ji HY, Youn YS, Lee KC, Lee HS. Analysis of carvedilol in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry. J Pharm Biomed Anal. 2007 Jun;44(2):547-552
    • (2007) J Pharm Biomed Anal , vol.44 , Issue.2 , pp. 547-552
    • Jeong, D.W.1    Kim, Y.H.2    Ji, H.Y.3    Youn, Y.S.4    Lee, K.C.5    Lee, H.S.6
  • 29
    • 0003484310 scopus 로고    scopus 로고
    • U.S. Department of Health and Human Services, Food and Drug Administration. Federal Register
    • Guidance for Industry, Bioanalytical Method Validation. U.S. Department of Health and Human Services, Food and Drug Administration. Federal Register. 2001;66.
    • (2001) Guidance for Industry, Bioanalytical Method Validation , vol.66
  • 30
    • 33646551011 scopus 로고    scopus 로고
    • The European Agency for the Evaluation of Medicinal Products, Committee for Proprietary Medicinal Products. CPMP/EWP/QWP/1401/98
    • Guidance on the Investigation of Bioavailability and Bioequivalence. The European Agency for the Evaluation of Medicinal Products, Committee for Proprietary Medicinal Products. 2001; CPMP/EWP/QWP/1401/98.
    • (2001) Guidance on the Investigation of Bioavailability and Bioequivalence


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.